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Abstract
 
Lymphocytes residing in the intestinal epithelium are exclusively T cells and account for one of
the largest collection of T cells in the organism. However, their function remains obscure. We
and others have shown that the development of intestinal intraepithelial T cells is compromised
in mutant mice prone to chronic intestinal inflammation. These results led us to directly assess
their role in regulating the development of colitis secondary to transfer of primary splenic
 
TCR
 
  
 
 
 
CD4
 
 
 
CD45RB
 
hi
 
 T cells into severe combined immunodeficiency (SCID) mice.
Here we demonstrate that prior reconstitution of SCID recipients with intraintestinal
 
TCR
 
  
 
 
 
CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
 T cells prevents disease, and does so in an interleukin (IL)-10–
 
dependent fashion. In contrast, reconstitution with either TCR
 
  
 
 
 
 or TCR
 
  
 
 
 
CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
 intestinal T cells did not prevent colitis. TCR
 
  
 
 
 
CD4
 
 
 
8
 
 
 
 
 
 
 
 
 
 T cells are unique
to the intestinal epithelium of both rodents and humans. Previous repertoire analyses of
TCR
 
  
 
 
 
CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
 T cells revealed a high proportion of cells expressing high affinity,
self-specific TCR within this subset. We demonstrate that monoclonal, self specific
TCR
 
  
 
 
 
CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
 cells derived from TCR transgenic mice also prevent the onset of
colitis. Thus, intestinal TCR
 
  
 
 
 
CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
 T cells, selected based on their self-reactiv-
ity, maintain gut integrity in a IL-10–dependent fashion.
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CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
 IEL • IL-10 • IBD
 
Introduction
 
There is general consensus that inflammation of the intes-
tinal mucosa results from a dysregulated response of
CD4
 
 
 
TCR
 
  
 
 
 
 T cells, resident within the intestinal lam-
ina propria, to environmental antigen(s), in genetically sus-
ceptible individuals (1). Further, it has been proposed that
onset of disease is due to an imbalance between regulatory
and inflammatory subsets of CD4
 
 
 
 T cells (1).
Evidence has accumulated over the last 10 yr which es-
tablished the T lymphopoietic capacity of the murine intes-
tinal mucosa (2–5). Indirect evidence supports this conclu-
sion in humans as well (6). Analyses of intraintestinal
mononuclear cells (MNCs) developing in athymic radia-
tion chimeras has enabled the phenotypic characterization
of the various subsets of gut-derived T cells.
The first important observation is that donor-derived T
cells are found on both sides of the basement membrane of
the intestinal epithelium in numbers comparable to those
 
observed in unmanipulated animals (2, 4, 7). Among
intraepithelial T lymphocytes (iIELs), 30–50% express
TCR
 
  
 
. The remaining CD3
 
 
 
 iIELs express a high level
of TCR
 
  
 
. 5–10% express CD4 only, while 5–30%, in an
age- and strain-dependent fashion, coexpress high levels of
CD4 and the 
 
 
 
 chain of CD8. The remaining 60–80% of
TCR
 
  
 
 
 
 iIELs are divided into two subsets of roughly
equal size, those expressing only the 
 
 
 
 chain of CD8, and
those coexpressing CD8
 
 
 
 and CD8
 
 
 
. In humans, the latter
two TCR
 
  
 
 
 
 subsets account for virtually all iIELs (8).
Murine TCR
 
  
 
 
 
 
 
iIELs are also distinguished based on
their differential expression of functional antigen receptor
complexes. Specifically, the CD4
 
 
 
CD8
 
 
 
 and CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
 subsets express functional TCR/CD3 com-
 
plexes (4, 7, 9), while CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
 and CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
TCR
 
  
 
 
 
 iIEL subsets are refractory to antigen, superanti-
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gen, anti-TCR
 
  
 
 stimulation (4, 7, 9). However, these
latter subsets do respond to lectin (4), and mAb specific for
CD3 (4), in vitro.
There is evidence that the selection of CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
TCR
 
  
 
 
 
 iIELs is unique (4, 10, 11). Specifi-
cally, this subset is comprised of a mixture of cells, some
specific for antigen presented by classical MHC class I mol-
ecules (12), and others recognizing antigen presented by
molecules encoded by the Qa-2 locus (13). What is re-
markable is that the development of CD4
 
 
 
CD8
 
 
 
 
 
 
 
 
 
TCR
 
  
 
 
 
 iIELs restricted by classical MHC class I is
predicated by the expression of high affinity, self-specific
TCR (10).
The first indication that iIELs play a role in the mainte-
nance of mucosal integrity was derived from the analysis of
IL-2/IL-2R–deficient mice, which are prone to IBD (14).
The analysis of euthymic and athymic hemopoietic radia-
tion chimeras demonstrated the lack of intraintestinal T
lymphopoiesis in IL-2
 
 
 
/
 
 
 
, IL-2R
 
 
 
 
 
/
 
 
 
, and IL-2R
 
 
 
 
 
/
 
 
 
mice. The absence of IBD in athymic radiation chimeras,
and the presence of intestinal inflammation in euthymic re-
cipients of hemopoietic precursors derived from the above
three strains demonstrated the central role of thymus-
derived T cells resident in the intestinal mucosa as media-
tors of disease, and the importance of a normal comple-
ment of gut-derived T cells in the maintenance of intestinal
integrity. The above results are consistent with previous re-
sults demonstrating that normal thymus-derived T cells can
induce gut inflammation upon adoptive transfer to T cell–
deficient animals (15, 16). Specifically, when low numbers
of CD4
 
 
 
CD45RB
 
hi
 
 T cells of thymus origin cells are pas-
sively transferred into SCID mice, lacking both gut- and
thymus-derived T cells, donor T cells migrate to the intes-
tinal mucosa, expand, secrete proinflammatory cytokines,
and induce an ulcerative colitis-like syndrome in the recip-
ients (16). Furthermore, and in the context of this model
system, it was demonstrated that TCR
 
  
 
 
 
CD4
 
 
 
CD45RB
 
low
 
 T cells of thymus origin prevented the devel-
opment of this syndrome (16), and did so in an IL-10–
dependent fashion (17).
In this study, we directly assessed the capacity of specific
iIEL subsets to protect the intestinal mucosa from chronic
inflammation induced by TCR
 
  
 
 
 
CD4
 
 
 
CD45RB
 
hi
 
 T
cells of thymic origin.
 
Materials and Methods
 
Animals.
 
Ly5.2 C57Bl/6, SCID.C57Bl/6, and IL-10
 
 
 
/
 
 
 
C57Bl/6 mice were purchased from The Jackson Laboratory.
Ly5.1 C57Bl/6 mice and Ly5.2, recombination activating gene
(RAG)-2
 
 
 
/
 
 
 
, C57Bl/6 mice transgenic for HY/H2D
 
b
 
-specific
TCR
 
   
 
(10) were bred in our animal facility. Prior to transfer,
both donors and recipients (7–10 wk old) were bred and main-
tained under specific pathogen-free conditions. Bimonthly assess-
ment of sentinel mice failed to detect viruses, parasites, or patho-
genic bacteria (including 
 
Helicobacter sp.
 
) throughout the course of
the study. After adoptive transfer of MNCs, recipients were fed
non-sterile food and water, and the filter tops of their cages were
 
removed. Three times a week, recipients were weighed and ex-
amined for the presence of diarrhea, bloody stools, and rectal
prolapse. Animals were killed when body weight loss was 
 
 
 
20%,
and/or any combination of the three other intestinal symptoms
developed, or at 150 d.
 
Monoclonal Antibodies, Three-Color Immunofluorescence, FACS
 
®
 
Analysis, Cell Preparation, Cell Sorting, and Cell Transfer.
 
The
preparation of iIELs and lamina propria (LP) lymphocytes, and
the monoclonal antibodies used in this study have been described
previously (4, 7, 14, 16). Cells were then analyzed by flow cy-
tometry on a Becton Dickinson FACSCalibur™ or sorted using a
Moflo (Cytomation, Inc.). At least 10
 
4
 
 cells/sample were ac-
quired for analysis. The absolute number of cells within an MNC
subset was calculated by multiplying the total number of MNCs
isolated by the proportion of cells accounted for by this subset.
The total number of MNCs from the intestinal epithelium and
lamina propria was determined before their purification by dis-
continuous Percoll gradient centrifugation.
For sorting, iIELs and splenocyte suspensions were pre-
pared and stained in sterile conditions with the appropriate
combination of fluorochrome-conjugated antibodies (4). The
purity of sorted iIEL and splenocyte subsets was analyzed be-
fore their injection into SCID recipients and was always
 
 
 
99%.
For iIEL reconstitution, a total number of 5 
 
 
 
 10
 
6
 
 cells from
each of the studied iIEL subsets was administered intravenously to
the SCID recipients. Adoptive transfer of TCR
 
  
 
CD4 
CD45RBhi splenic T cells (0.5   106/recipient) was performed
intravenously 1 wk after the iIEL reconstitution.
Histology. The gut of experimental animals was differentially
processed for histological examination depending on whether
suspensions of MNCs from the intestinal epithelium and lamina
propria were also prepared for flow cytometry analysis. Prior to
the preparation of suspensions of gut-derived MNCs, 3 proximal,
median, and distal fragments (5–10 mm long) of both small and
large bowel were collected for histological examination. For the
other experimental animals, the entire length of small and large
bowel from SCID recipients was wrapped to form a roll before
fixation in 10% neutral buffered formaldehyde for 24 h. Speci-
mens were then embedded in paraffin and three 6- m sections
were taken 250  m apart through the entire thickness of the
bowel loops. Each section was stained with hematoxylin and
eosin. Each section was examined and scored in a blind fashion
by one of us (D. Banerjee) as described (17). Briefly, grade 0 cor-
responded to the absence of histological abnormalities; grade 1 to
the presence of minimal and scattered inflammatory cell infil-
trates, with or without minimal epithelial hyperplasia; grade 2 to
mild scattered to diffuse inflammatory cell infiltrates, sometimes
invading the submucosa and associated with erosions, with mini-
mal to mild epithelial hyperplasia, and minimal to mild loss of
mucin from goblet cells; grade 3 to mild to moderate inflamma-
tory cell infiltrates, sometimes transmural, often associated with
ulceration, with moderate epithelial hyperplasia, and loss of mu-
cin; grade 4 to severe inflammatory cell infiltrates, often transmu-
ral and associated with ulceration, with marked epithelial hyper-
plasia, and loss of mucin; grade 5 to severe, transmural
inflammatory cell infiltrates, with severe ulceration and loss of in-
testinal crypts.
Statistical Analysis. The Mann-Whitney test and log-rank
analysis were applied to compare histological scores and Kaplan-
Meier survival curves, respectively. Student’s t test was applied to
weight variations. Differences were considered as statistically sig-
nificant with P   0.05.1493 Poussier et al. Brief Definitive Report
Results and Discussion
CD4 8    TCR    iIELs Protect Against Colitis. We
used the murine model which led to the original character-
ization of CD4 CD45RBhiTCR    thymus-derived T
cells expressing a Th1 cytokine pattern, as potent inducers
of colitis when injected into histocompatible SCID recipi-
ents (16, 18). As illustrated in Figs. 1, 2 A, and 2 C, mild to
severe colitis developed in 22/26 Ly 5.2 SCID.B6 recipi-
ents of 0.5   106 splenic TCR   CD4 CD45RBhi T
cells derived from Ly 5.1 C57Bl/6 donors in 150 d. All an-
imals that developed clinical symptoms had severe lesions
restricted to the colon (Fig. 3 a). Animals were considered
as colitis free only when clinically normal and devoid of
histological abnormalities.
The capacity of three iIEL subsets to regulate the course
of colitis was assessed. Specifically, 1 wk before the adoptive
transfer of splenic TCR   CD4 CD45RBhi T cells, re-
cipients were reconstituted with 5   106 cells of one of the
three following iIEL subsets: CD4 CD8     TCR   ,
CD4 CD8    TCR   , or TCR    isolated from Ly
5.2 C57Bl/6 donors. As illustrated in Figs. 1, 2 A, 2 C, and
3 b, 8/10 recipients of CD4 CD8    TCR    iIELs re-
mained disease free for up to 150 d. In contrast, 5/5 recipi-
ents of CD4 CD8    TCR    iIEL and 14/18 recipi-
ents of TCR    iIELs developed mild to severe colitis
(Figs. 1, 2 A, and 2 C).
The results presented herein demonstrate a heretofore
unrecognized function of iIELs. Specifically, of the two
major subsets of iIELs in rodents and humans (8, 11, 19),
those expressing CD4 CD8    TCR    and those ex-
pressing CD4 CD8    TCR   , we demonstrate that
the former but not the latter can function to protect gut in-
tegrity in the presence of thymus-derived inflammatory T
cells. In this regard, it is of note that there is precedent for
the role of iIELs in modulating systemic immune responses.
Specifically, TCR   , iIELs have been shown to modulate
low dose oral tolerance induction in an IL-10–dependent
fashion (20).
Protective iIELs Regulate Numbers of CD4  T Cells in
the Colonic Lamina Propria. The use of CD45 congenic
C57Bl/6 lines enabled us to discriminate amongst recipi-
ent, donor-derived splenic T cells and iIELs, and hence to
assess the fate of donor-derived T cell subsets.
Tracking of donor T cell subsets using this strain combi-
nation demonstrated that the inability of an iIEL subset to
afford protection was not related to its capacity to reconsti-
tute the iIEL compartment of the recipient. As illustrated in
Table I,  95% of donor (Ly 5.2) iIELs were rescued from
the iIEL compartment of recipient small bowel while  2%
of these donor cells were rescued from secondary lym-
phoid organs. Further, the total number of donor-derived
Figure 1. Differential susceptibility to colitis in
SCID.C57Bl/6 recipients of various iIEL subsets and
splenic CD4 CD45RBhiTCR    T cells. Significant
(P     0.01) protection from colitis was afforded by
CD4 CD8    TCR    iIELs. Results taken from
two of the 2–8 experiments performed.
Figure 2. Differential susceptibility to
colitis in SCID.C57Bl/6 recipients of
various iIEL subsets and splenic
CD4 45RBhiTCR    T cells. (A and
B) Weight variations over time of ex-
perimental groups of recipients. Data
represent the mean   SEM. (A) Statisti-
cal significance (Student’s t test): no re-
constitution ( ) versus reconstitution
with CD4 CD8    TCR    iIELs
( ),  P    0.02; no reconstitution ( )
versus reconstitution with TCR   
iIELs ( ) or CD4 CD8    TCR   
iIELs ( ), not significant. (B) Reconsti-
tution with CD4 CD8    TCR   
iIELs ( ) versus IL-10 / CD4 CD8    TCR    iIELs ( ), P   0.05. (C) Pathology scores of individual animals from experimental groups of recip-
ients. Statistical significance (Mann-Whitney test): no reconstitution versus reconstitution with CD4 CD8    TCR    iIELs, P   0.002; no reconsti-
tution versus reconstitution with TCR    iIELs or CD4 CD8    TCR    iIELs, not significant; reconstitution with CD4 CD8    TCR   
iIELs versus IL-10 / CD4 CD8    TCR    iIELs, P   0.0005; no reconstitution versus reconstitution with IL-10 / CD4 CD8    TCR   
iIELs, P   0.05.1494 Regulatory Intraintestinal T Cells
CD4 CD8    TCR   , CD4 CD8    TCR   , and
TCR    iIELs recovered was not significantly different,
and hence differential reconstitution did not correlate with
protection. Of note, the number of rescued cells approxi-
mated the number of cells injected, and their membrane
CD4/CD8 phenotype remained unchanged.
While the majority of the cells derived from the injected
Ly 5.1 TCR   CD4 CD45RBhi were rescued in the
small bowel of recipients (Table I), these animals showed
no small bowel pathology. The cells homed to both the
iIEL and LP compartments of the small bowel with compa-
rable efficiency, and the number of donor cells rescued was
16–60-fold higher than the number of injected cells. Hom-
ing of the progeny of CD4 45RBhi cells to the recipient
spleen and lymph nodes only amounted to 3–13% of the
number of cells of the same origin recovered from the re-
cipient gut (Table I).
The lamina propria of the large bowel was the exclusive
site where the number of cells derived from Ly 5.1
TCR   CD4 CD45RBhi T cells was differentially and
Figure 3. Histological analysis of the colonic
mucosa from representative SCID.C57Bl/6 re-
cipients of CD4 CD45RBhiTCR    T cells and
different iIEL subsets. (a) Severe colitis in a
SCID.C57Bl/6 recipient of CD4 CD45RBhi
TCR    T cells. (b) Lack of colitis in a
SCID.C57Bl/6 recipient of CD4 CD8  
  TCR    iIELs and CD4 CD45RBhi
TCR    T cells. (c) Severe colitis in a
SCID.C57Bl/6 recipient of IL-10 /   CD4 
CD8    TCR    iIELs and CD4 CD45RBhi
TCR    T cells. Hematoxylin and eosin
stain; original magnification:  100.
Table I. Numbers (Mean   SEM) of Donor-derived Lymphocytes in the Intestinal Mucosa and Secondary Lymphoid Organs (Spleen and 
Lymph Nodes) of SCID.C57Bl/6 Recipients (n   3–5/Group Derived from 2–3 Experiments Killed at the Onset of Clinical Colitis or at
150 d).
iIEL subsets transferred prior to administration of CD4 CD8 CD45RBhighTCR   splenocytes
Donor lymphocytes No iIEL CD8    TCR    CD8    TCR    IL-10 / CD8    TCR    TCR   
CD4 CD45RBhiTCR   
S.B. iIEL 1.4   0.8   107 8.3   1.4   106 5.1   1.4   106 9.2   0.9   106 2.0   0.7   107
LP 1.7   0.9   107 8.7   1.9   106 8.8   1.9   106 2.0   2   107 6.2   1   106
iIEL 0.3   0.1   106 0.5   0.1   105 0.4   0.2   105 1.1   0.2   105 1.2   0.3   105
L.B. LP 8.3   0.3   106 8.6   0.4   106 1.4   0.3   106a 9.9   0.6   106 6.9   0.4   106
Spleen plus LN 5.0   1.7   106 0.8   0.6   106 1.8   1.0   106 3.2   1.1   106 1.2   0.6   106
iIEL
S.B. iIEL NA 7   0.4   106 5.8   0.7   106 5.2   0.4   106 1   0.4   107
LP NA 0.5   0.3   106 0.3   0.3   106 0.3   0.3   106 0.8   0.3   106
L.B. iIEL NA 0.2   0.2   105 0.3   0.1   105 0.4   0.3   105 0.4   0.3   106
LP NA 0.4   0.2   106 0.2   0.2   105 0.4   0.2   105 0.4   0.3   105
Spleen plus LN NA 1.3   0.6   105 1.0   0.8   105 6.4   1.4   105 2.5   1.6   104
aStatistically significant (P   0.05, Mann-Whitney test) compared to other groups of recipients. L.B., large bowel; S.B., small bowel.1495 Poussier et al. Brief Definitive Report
significantly affected by the subset of reconstituting iIELs.
Specifically, 8–9-fold more CD4  T cells were rescued
from this site in animals that developed colitis compared
with those healthy recipients of protective CD4 CD8  
  TCR    iIELs (Table I).
It is striking that protective iIELs were rescued almost
exclusively in the small bowel. While consistent with the
location of this subset in conventional animals, this study
reveals two remarkable facts. The cells derived from
CD4 CD45RBhi TCR    T cells expanded 50–100-fold
in all animals, independent of iIEL reconstitution. How-
ever, the majority of the progeny were found in the intesti-
nal mucosa of the small bowel, which was free of pathol-
ogy. The influence of the reconstituting iIEL subsets was
only observed in the lamina propria of the large bowel. We
conclude that progeny of CD4 CD45RBhiTCR    T
cells resident in the small bowel must not be pathogenic,
and that the protective function of CD4 CD8  
  TCR    iIELs does not involve direct interaction with
inflammatory effector cells.
Protection Against Colitis Afforded by CD4 CD8    
TCR    iIELs Is IL-10–dependent. When adoptive trans-
fer of Ly 5.1 TCR   CD4 CD45RBhi splenic T cells was
preceded by reconstitution of the recipients with 5   106
CD4 CD8    TCR    iIELs derived from IL-10 / 
donors, mild to severe colitis developed in 9/10 animals,
compared with 1/10 animals reconstituted with IL-10 / 
CD4 CD8    TCR    iIELs (Figs. 2 C, 3, and 4, and
Table I). Importantly, this lack of protection was not related
to an impaired iIEL reconstitution, as the number of donor-
derived CD4 CD8    TCR    iIELs rescued approxi-
mated the number of injected cells independent of their IL-
10 genotype (Table I). Notwithstanding, the number of
cells derived from donor TCR   CD4 CD45RBhi T cells
within the lamina propria of the large bowel was signifi-
cantly higher in recipients of IL-10 /  CD4 CD8    
TCR    iIELs (Table I), and comparable to that observed
in both unreconstituted animals and recipients of nonpro-
tective, IL-10 /  iIELs (Table I). Of note, reconstitution of
SCID.B6 mice with CD4 CD8    TCR    iIELs de-
rived from IL-10 /  donors did not result in the develop-
ment of colitis in the absence of subsequent injection of
TCR   CD4 CD45RBhi splenic T cells (data not
shown).
The IL-10–dependent protection afforded by CD4 
CD8    TCR    iIELs is consistent with a previous
report demonstrating that administration of exogenous
IL-10 to recipients of CD4 CD45RBhiTCR    T cells
prevents colitis (18). However, we have been unable to
obtain evidence for the capacity of CD4 CD8    
TCR    iIELs to secrete IL-10. Specifically, we have as-
sessed the secretion of IL-10 by FACS®-purified ( 99%)
CD4 CD8    TCR    iIELs in vitro, without stimula-
tion, as well as in response to a combination of plate bound
anti-CD3 and anti-CD28 monoclonal antibodies. In both
circumstances, CD4 CD8    TCR    iIELs failed to
secrete IL-10 (data not shown). Further, we did not detect
surface expression of IL-10R on CD4 CD8    TCR   
iIELs flow cytometrically (data not shown). These results,
which are consistent with those of a recent study showing
very low levels of transcripts for both IL-10 and IL-10R in
iIELs expressing TCR   (21), strongly suggest that the IL-
10 dependency of protection conferred by this subset is in-
direct. Importantly, murine enterocytes which are in phys-
ical contact with iIELs, constitutively express IL-10R (22).
It is not implausible that the differentiation of CD4 
CD8    TCR    iIELs into effector regulatory T cells
depends on signals generated by surrounding enterocytes
induced by IL-10.
Self-specific CD4 CD8    TCR    iIELs Protect
Against Colitis. One of the paradoxes of intraintestinal T
cell development is the presence of CD4 CD8    
TCR    iIELs expressing potentially self-specific TCR.
In conventional mice this subset, while oligoclonal, con-
tains high proportions of cells expressing V  specific for
endogenous retroviral superantigens (4, 11, 23). Analysis of
RAG-deficient animals transgenic for MHC class I–restricted
TCR has demonstrated that CD4 CD8     TCR   
iIELs expressing the transgenic TCR develop in animals
that express both the restricting MHC and the specific
Figure 4. Protection of SCID.C57Bl/6 recipients of splenic
CD4 CD45RBhiTCR    T cells from colitis by CD4 CD8    
TCR    iIELs is IL-10 dependent. Reconstitution with CD4 CD8  
  TCR    iIEL ( ) versus IL-10 /  CD4 CD8    TCR    iIELs
( ), P   0.008; no reconstitution ( ) versus reconstitution with IL-
10 / CD4 CD8    TCR    iIELs ( ), not significant. Results taken
from two of the 3–8 experiments performed.
Figure 5. Self-specific CD4 
CD8    TCR    iIELs pro-
tect SCID.C57Bl/6 recipients of
splenic CD4 CD45RBhiTCR   
T cells from colitis. Pathology
scores of individual male ( ) and
female ( ) SCID.C57Bl/6 re-
cipients of CD4 CD8    
iIELs expressing an HY/Db-spe-
cific transgenic TCR  , and
splenic CD4 CD45RBhiTCR    T cells derived from male donors.
Significant (P   0.05) protection of male recipients was observed.1496 Regulatory Intraintestinal T Cells
antigen, exclusively (7, 10, 12). Thus, 100% of the CD4 
CD8     iIEL subset in RAG /  H-2Db male mice
transgenic for a H-Y/H-2Db-specific TCR  , express
high levels of the transgenic TCR. This enabled us to di-
rectly assess the protective capacity of self-specific CD4 
CD8     iIEL against intestinal inflammation.
Toward this end, 5   106 CD4 CD8     iIELs de-
rived from RAG /  H-2Db male mice transgenic for a
H-Y/H-2Db-specific TCR   were used to reconstitute
Ly 5.2 SCID.B6 male (n   5) and female (n   3) recipi-
ents. As illustrated in Fig. 5, of the male recipients only
one developed severe colitis within 150 d after the trans-
fer of 0.5   106 splenic CD4 CD45RBhi T cells derived
from male Ly 5.1 C57Bl/6 donors (Fig. 5). The female
recipients, which provided a specificity control in this sys-
tem, all developed severe colitis within the same time
frame (Fig. 5).
These results formally validate the capacity of self-spe-
cific T cells within the CD4 CD8     iIEL subset to
protect the intestinal mucosa against chronic inflammation.
Thus, positive selection of self-specific CD4 CD8    
TCR    T cells, which is restricted to the intestinal epi-
thelium, is advantageous to the integrity of the intestinal
mucosa. Of note, the positive selection of self-specific T
cells is not unique to the murine intestinal epithelium. Spe-
cifically, dendritic epidermal T cells are monoclonal, and
protect the cutaneous epithelium in response to self antigen
subsequent to injury (24).
It is tempting to speculate that CD4 CD8    TCR   
iIEL, present in other species, including humans (8) fulfill a
similar role in the maintenance of intestinal integrity. The
observation that exogenous IL-10 is inefficient in amelio-
rating symptoms of inflammatory bowel disease in humans
(25), would suggest that, if protective, human CD4 CD8  
  TCR    iIELs, may not function in an IL-10–depen-
dent manner. However, results obtained in murine models
of colitis underscore the importance of the methodology
used to assess the role of IL-10 in regulating IBD. Specifi-
cally, the first attempt to demonstrate its role, involved the
administration of neutralizing antibodies, and was unsuc-
cessful. In contrast, subsequent studies established that ei-
ther systemic administration of IL-10, or the forced expres-
sion of IL-10 in CD4 CD45RBhi TCR    T cells,
prevented colitis (18, 26). Hence, resolution of the appar-
ent discrepancy regarding the role of IL-10 in humans may
require the assessment of various regimens of IL-10 admin-
istration, minimally the assessment of outcome in circum-
stances in which it is certain that IL-10 reaches the target
organ. Furthermore, murine models of inflammatory
bowel diseases have not established the capacity of IL-10 to
reverse the course of ongoing colitis, rather, its effective-
ness in preventing the development of chronic inflamma-
tion. It is therefore inappropriate to compare the preven-
tive role of IL-10 in murine colitis with its curative role in
humans with established inflammatory bowel disease.
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